![]() |
17th International AIDS ConferenceMexico City, Mexico - August 13 - 18, 2008 |
THE MECHANISM OF SEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) VIA THE FORESKIN EPITHELIUM
Int Conf AIDS. 2008 Aug 13-18;17 Abstract No. MOAA0301
Y. Ganor
1, A. Schmitt2, J.P. Wolf3, M.C. Vacher-Lavenu4, L. Gibault4, N. Thiounn5, J. Tomasini6, M. Bomsel1
1Institute Cochin, Cell Biology, CNRS (UMR 8104), Inserm (U567), Paris, France, 2Institute Cochin, Electron Microscopy Platform, CNRS (UMR 8104), Inserm (U567), Paris, France, 3Cochin-St Vincent de Paul Hospitals Group, Reproductive Biology
Service, Paris, France, 4Cochin-St Vincent de Paul Hospitals Group, Anatomy and Pathological Cytology Service, Paris, France, 5Necker Hospital, Urology Service, Paris, France, 6Geoffroy St Hillaire Clinic, Paris, France
BACKGROUND: The first steps of sexual transmission of the human-immunodeficiency-virus (HIV) at different mucosal sites involve transport of HIV across epithelial barriers covering the skin / mucosal surfaces, including the male genitals. Although male circumcision was reported to reduce male acquisition of HIV by >60%, the initial mechanism of HIV transmission at the male genitals remains elusive. A chief problem in studying the early phases of foreskin HIV infection is the lack of proper in-vitro model systems that reflect the in-vivo architecture.
METHODS: We established a novel in-vitro immunocompetent model of the human foreskin. It includes a fibrous sheet produced by foreskin fibroblasts that are topped by differentiating keratinocytes, from either inner/outer aspects of the foreskin. Dendritic cells (DCs) and/or Langerhans cells (LCs) are further integrated into the model. In parallel, we also developed an ex-vivo polarized foreskin explant model.
RESULTS: We found that upon apical exposure to cell-associated HIV, virus particles translocate rapidly across reconstructions, while translocation of cell-free HIV is extremely limited. Moreover, HIV is translocated more efficiently via:
In addition, ex-vivo exposure of normal foreskin explants to cell-associated HIV results in entrapment of viral particles in the thicker keratin layer of the outer foreskin, along with migration of LCs to the upper epithelium sending dendrites to the lumen.
Finally, seminal plasma (SP) from HIV-negative men mixed with cervico-vaginal secretions (CVS) from HIV-positive women, which mimics the in-vivo mixture of these genital secretions during woman-to-man HIV sexual transmission, decreased HIV infection at the foreskin.
CONCLUSIONS: Our findings suggest an active role of DCs/LCs in sampling of luminal virus followed by their migration out of the epithelium. This process is more efficient at the inner aspect of the foreskin, and may be inhibited by yet ill-defined components present in SP/CVS.
Download PDF of this abstract.
2008-08-13
MOAA0301
Copyright © 2008 - International AIDS Society (IAS). All information and content relating to the abstracts from the 16th International AIDS Conference, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.
AEGiS is a 501c(3) not-for-profit organization made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, GlaxoSmithKline, the National Library of Medicine, Roche / Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.